PEOPLE - MediSpectra makes appointments:
This article was originally published in Clinica
Executive Summary
MediSpectra, a US developer of optical biopsy systems to detect cervical cancer, has elected Richard Thomas and Kim Blickenstaff to its board of directors. Mr Thomas is president of NeuroMetrix, and Mr Blickenstaff is CEO of Biosite Diagnostics.